Hrt Financial LP Cti Biopharma Corp Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$4.45 - $6.17 $223,950 - $310,511	50,326 New	50,326 $302,000
Q2 2021 Aug 16, 2021	SELL	$2.16 - $2.62 $419,562 - $508,914	-194,242 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.68 - $3.8 $165,310 - $234,395	61,683 Added 46.53%	194,242 $565,000
Q4 2020 Feb 16, 2021	BUY	$2.48 - $3.8 $328,746 - $503,724	132,559 New	132,559 $426,000
Q3 2020 Nov 13, 2020	SELL	$1.02 - $2.15 $20,104 - $42,376	-19,710 Closed	0 $0

Q2 2020 Aug 14, 2020	BUY	$0.88 - $1.32 $17,344 - $26,017	19,710 New	19,710 $22,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.